Relafen 750, pharmacologically known as naproxen sodium , offers a unique physiological mechanism of action. From a drug angle , it functions primarily as a non-copyrightal compound , inhibiting cyclooxygenase enzymes – notably COX-1 and COX-2 – to diminish inflammation and temperature . The ensuing decrease in inflammatory mediator synthesis i